Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cefpodoxime proxetil
Drug ID BADD_D00396
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D00920
MeSH ID C053267
PubChem ID 6321414
TTD Drug ID Not Available
NDC Product Code 0781-5439; 51810-052; 64980-403; 65862-140; 69292-512; 55289-393; 69292-514; 67877-878; 69292-510; 0781-5438; 16714-402; 51407-083; 65862-096; 65862-381; 64980-402; 65862-141; 69043-006; 61788-5000; 63785-112; 82608-013; 16714-403; 51407-084; 65862-095; 68071-3441; 16714-394; 16714-395; 67877-559; 67877-560; 69043-007; 57297-100; 67877-879; 68071-2742; 69292-516
UNII 2TB00A1Z7N
Synonyms cefpodoxime proxetil | 1-(isopropoxycarbonyloxy)ethyl-7-(2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido)-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo(4,2,0)-oct-2-ene-2-carboxylate | Vantin | U 76252 | U-76,252 | cephalosporin 807 | CS 807 | CS-807 | Doxef
Chemical Information
Molecular Formula C21H27N5O9S2
CAS Registry Number 87239-81-4
SMILES CC(C)OC(=O)OC(C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CSC(=N3)N)COC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rash23.03.13.001---
Rash maculo-papular23.03.13.004--
Rectal haemorrhage07.12.03.001; 24.07.02.018--
Rhinitis11.01.13.004; 22.07.03.006--
Serum sickness-like reaction08.01.03.003; 10.01.03.005---
Somnolence17.02.04.006; 19.02.05.003--
Stevens-Johnson syndrome10.01.01.045; 11.07.01.005; 12.03.01.014; 23.03.01.007--
Stomatitis07.05.06.005--
Thrombocytopenia01.08.01.002---
Thrombocytopenic purpura01.08.01.003; 23.06.01.007---
Thrombocytosis01.08.02.001---
Toxic epidermal necrolysis10.01.01.006; 11.07.01.006; 12.03.01.015; 23.03.01.008--
Urticaria10.01.06.001; 23.04.02.001--
Vomiting07.01.07.003--
Skin candida11.03.03.010; 23.11.03.009---
Haemorrhage24.07.01.002---
Blood alkaline phosphatase increased13.04.02.004--
Coombs test positive13.01.01.002---
Decreased appetite08.01.09.028; 14.03.01.005--
Renal impairment20.01.03.010---
Liver injury09.01.07.022; 12.01.17.012---
Foetal exposure during pregnancy12.03.07.001; 18.08.05.001---
Candida infection11.03.03.021--
The 3th Page    First    Pre   3    Total 3 Pages